4//SEC Filing
Thompson David E. 4
Accession 0001214659-13-002918
CIK 0001316175other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 7:10 PM ET
Size
5.4 KB
Accession
0001214659-13-002918
Insider Transaction Report
Form 4
Thompson David E.
Director
Transactions
- Award
Stock Option (right to buy)
2013-05-17+100,000→ 100,000 totalExercise: $0.61Exp: 2023-05-16→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments from the grant date of May 17, 2013. This stock option is fully exercisable on May 17, 2014.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
Related Parties
1- filerCIK 0001484500
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 7:10 PM ET
- Size
- 5.4 KB